Search results - 25 results
Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI)
and infrastructure. The ongoing Genomic Data Infrastructure (GDI) project aims to capitalise on the experience of B1MG piloting countries and their MLM results. In this paper, we present the qualitative ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
will assess the quality of studies using QUADAS-2 and QUADAS-C. ETHICS AND DISSEMINATION: Ethical approval is not required. Results will be disseminated to academic beneficiaries, medical practitioners, ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
women diagnosed with histologically confirmed cervical intraepithelial neoplasia two or more (≥ CIN2, N=119) and controls defined as women with two subsequent negative cytology results (N=834). RESULTS ...
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
Abstract: BACKGROUND: The COVID-19 pandemic highlighted the importance of diagnostic testing against curbing the spread of SARS-CoV-2. The urgent need and scale for diagnostic tools resulted in manufacturers ...
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services
professionals (gynecologists, general practitioners, and midwives) through semi-structured interviews. Results indicated that health professionals believe that self-sampling may address the issues of low ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Infections Real-Time Polymerase Chain Reaction Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: Human papillomavirus (HPV) assays used in ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
absolute participation differences. RESULTS: Thirty-three trials were included. In the intention-to-treat analysis, all self-sampling invitation scenarios were more effective in reaching under-screened women ...
The Belgian DNA Debate: An Online Deliberative Platform on the Ethical, Legal, and Social Issues of Genomics
online DNA debate was organised, where 1,127 citizens contributed to its deliberative platform. Results: Contributors expressed a dual attitude towards the societal use of genomic information throughout ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
resulted in substantial decreases in the burden of cervical cancer in western and northern Europe; but in eastern Europe, cervical cancer incidence and mortality remain comparatively high. Today, new ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
RESULTS: Thirty-eight studies were eligible. The sensitivity of p16 staining for CIN3 + was significantly lower than that of hrHPV DNA testing (ratio for ASC- US, 0.87; 95% confidence interval [CI], ...